Literature DB >> 7925904

Community-based asthma care: trial of a "credit card" asthma self-management plan.

W D'Souza1, J Crane, C Burgess, H Te Karu, C Fox, M Harper, B Robson, P Howden-Chapman, L Crossland, K Woodman.   

Abstract

Although asthma self-management plans are widely recommended as essential in the long-term treatment of adult asthma, there have been few studies examining their use. Our objective was to assess the effect of a "credit card" adult asthma self-management plan in a community experiencing major health problems from asthma, by means of a before and after intervention trial of the efficacy of the "credit card" plan, when introduced through community-based asthma clinics. The participants were 69 Maori people with asthma. The "credit card" plan consisted of written guidelines for the self-management of asthma, based on self-assessment of asthma severity, printed on a plastic card. On one side, management guidelines were based on the interpretation of peak expiratory flow rate (PEFR) recordings, whilst the reverse side was based on symptoms. The outcome measures used were before and after comparison of markers of asthma morbidity and requirement for acute medical treatment; and a structured questionnaire assessing the acceptability and use of the credit card plan. Following the introduction of the plan, the mean PEFR increased from 347 to 389 l.min-1, the percentage of nights woken fell from 30.4 to 16.9%, and the number of days "out of action" fell from 3.8 to 1.7%. The requirements for acute medical treatment also fell during the intervention period. Most participants commented favourably on the content and usefulness of the plan. In the situation of worsening asthma, 28% of subjects found the peak flow side of the card most helpful, 7% the symptoms side, and 48% found both sides equally helpful.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 7925904     DOI: 10.1183/09031936.94.07071260

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  13 in total

Review 1.  Severe acute asthma.

Authors:  S Salmeron; M Bard; F X Blanc; A Ellrodt
Journal:  Clin Rev Allergy Immunol       Date:  1999       Impact factor: 8.667

2.  Pearce responds.

Authors:  Neil Pearce
Journal:  Am J Public Health       Date:  1997-12       Impact factor: 9.308

Review 3.  Written action plans for asthma: an evidence-based review of the key components.

Authors:  P G Gibson; H Powell
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

4.  Action plans in asthma management. Why, when, and how?

Authors:  S Janson
Journal:  West J Med       Date:  1996-09

5.  Impact of a nurse-led home management training programme in children admitted to hospital with acute asthma: a randomised controlled study.

Authors:  P Madge; J McColl; J Paton
Journal:  Thorax       Date:  1997-03       Impact factor: 9.139

6.  Peak flow based asthma self-management: a randomised controlled study in general practice. British Thoracic Society Research Committee.

Authors:  K P Jones; M A Mullee; M Middleton; E Chapman; S T Holgate
Journal:  Thorax       Date:  1995-08       Impact factor: 9.139

7.  Value of home peak flow monitoring for asthma control.

Authors:  S Janson
Journal:  West J Med       Date:  1995-10

8.  Structured discharge procedure for children admitted to hospital with acute asthma: a randomised controlled trial of nursing practice.

Authors:  L J Wesseldine; P McCarthy; M Silverman
Journal:  Arch Dis Child       Date:  1999-02       Impact factor: 3.791

Review 9.  Objectives, methods and content of patient education programmes for adults with asthma: systematic review of studies published between 1979 and 1998.

Authors:  P Sudre; S Jacquemet; C Uldry; T V Perneger
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

10.  Randomised comparison of guided self management and traditional treatment of asthma over one year.

Authors:  A Lahdensuo; T Haahtela; J Herrala; T Kava; K Kiviranta; P Kuusisto; E Perämäki; T Poussa; S Saarelainen; T Svahn
Journal:  BMJ       Date:  1996-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.